Table 1. Clinicopathological characteristics of patient samples and expression of AEG-1 in glioma.
Clinicopathological characteristics | All cases, n (%) |
Gender | |
Male | 33(42.3) |
Female | 45(57.7) |
Age (years) | |
<42 | 42(53.9) |
≥42 | 36(46.1) |
Clinical stage | |
I | 12(15.4) |
II | 16(20.5) |
III | 22(28.2) |
IV | 28(35.9) |
Clinical grade | |
Low-grade | 28(35.9) |
High-grade | 50(64.1) |
Histological types | |
Glioblastoma | 26(33.3) |
Astrocytomas | 41(52.6) |
Oligodendrogliomas | 8(10.3) |
Gliosaromas | 3(3.8) |
Expression of AEG-1 | |
Negative | 11(14.1) |
Positive | 67(85.9) |
Low expression | 36(46.2) |
High expression | 42(53.8) |
Tumor diameter (cm) | |
<4.5 | 29(37.2) |
≥4.5 | 49(62.8) |
Hyperspasmia | |
No | 62(79.5) |
Yes | 16(20.5) |